Skip to main content
Log in

Modified approach for apoptosis detection reveals changes in apoptotic processes in the seminoma-associated tissue

  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

Apoptosis morphology (DNA condensation) and internucleosomal DNA cleavage (TdT assay) were measured simultaneously on double fluorescence labeled testis tumor sections, employing conventional immunofluores cence microscopy. Six different apoptosis indices (AI) were determined based either solely on morphological or biochemical criteria, or on a combination of both processes. Measurements were performed in metastasized and non-metastasized seminoma, and in histological regions located distantly and associated with the tumor. Preliminary results on 19 histologies revealed that up to 66% of apoptotic cells were not detected, depending on the method used for apoptosis detection. Besides, no changes of solely morphologically defined AI was found in the different histological regions. By contrast, significant changes (p < 0.0004) in the different histological regions were detected when measuring AIs, e.g., defined by DNA fragmentation occuring without DNA condensation in apoptotic cells. Those changes were not detected in metastasized seminoma. These data, for the first time allow a comparison of two widely used approaches for apoptosis detection. Furthermore, the results reveal differences in apoptotic processes in tissue associated with non-metastasized seminoma detectable by a modified evaluated TdT assay but not by morphological changes, although this TdT method fails to show the total amount of apoptotic cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Czader M, Mazur J, Pettersson M, et al. Prognostic significance of proliferative and apoptotic fractions in low grade follicle center cell-derived non-Hodgkin's lymphomas. Cancer 1996; 77: 1180-1188.

    Google Scholar 

  2. Li WC, Kuszak JR, Wang GM, Wu ZQ, Spector A. Calcimycin-induced lens epithelial cell apoptosis contributes to cataract formation. Exp Eye Res 1995; 61: 91-98.

    Google Scholar 

  3. Shoji Y, Saegusa M, Takano Y, Ohbu M, Okayasu I. Correlation of apoptosis with tumor cell differentiation, progression, and HPV infection in cervical carcinoma. J Clin Pathol 1996; 49: 134-138.

    Google Scholar 

  4. Falkvoll KH. The occurrence of apoptosis, abnormal mitosis, cells dying in mitosis and micronuclei in a human melanoma xenograft exposed to single dose irradiation. Strahlenther Onkol 1990; 166: 487-492.

    Google Scholar 

  5. Stephens LC, Hunter NR, Kian Ang K, Milas L, Meyn RE. Development of apoptosis in irradiated murine tumors as a function of time and dose. Radiat Res 1993; 135: 75-80.

    Google Scholar 

  6. Meyn RE, Stephens LC, Kian Ang K, et al. Heterogeneity in the development of apoptosis in irradiated murine tumors of different histologies. Int J Rad Biol 1993; 64: 583-591.

    Google Scholar 

  7. Gorczyca W, Tuziak T, Kram A, Melamed MR, Darzynkiewicz Z. Detection of apoptosis-associated DNA strand breaks in fine-needle aspiration biopsies by in situ end labeling of fragmented DNA. Cytometry 1994; 15: 169-175.

    Google Scholar 

  8. Kerr JFR, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972; 26: 239-257.

    Google Scholar 

  9. Abend M, Schmelz HU, Kraft K, Rhein AP, van Beuningen D, Sparwasser C. Intercomparison of DNA apoptosis morphology with active DNA cleavage on single cells in vitro and on testis tumors. J Pathol 1998; 185: 419-426.

    Google Scholar 

  10. Ashwell JD, Berger NA, Cidlowski JA, Lane DP, Korsmeyer SJ. Coming to terms with death: apoptosis in cancer and immune development. Immunol Today 1994; 15: 147-151.

    Google Scholar 

  11. Isaacs JT. Advances and controversies in the study of programmed cell death/apoptosis in the development of and therapy for cancer. Curr Opin Oncol 1994; 6: 82-89.

    Google Scholar 

  12. Sugihara A, Saiki S, Tsuji M, et al. Expression of Fas and Fas ligand in the testes and testicular germ cell tumors: an immunohistochemical study. Anticancer Res 1997; 17: 3861-386.

    Google Scholar 

  13. Suda T, Takahashi T, Golstein P, Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993; 75: 1169-1178.

    Google Scholar 

  14. Niehans GA, Brunner T, Frizelle, et al. Human lung carcinomas express Fas ligand. Cancer Res 1997; 57: 1007-1012.

    Google Scholar 

  15. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD 95 ligand in preventing graft rejection. Nature 1995; 377: 630-632.

    Google Scholar 

  16. Griffith TS, Ferguson TA. The role of FasL-induced apoptosis in immune privilege. Immunol Today 1997; 18: 240-244.

    Google Scholar 

  17. Suda T, Okazaki T, Naito Y, et al. Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995; 154: 3806-3813.

    Google Scholar 

  18. Lee J, Richburg JH, Younkin SC, Boekelheide K. The Fas system is a key regulator of germ cell apoptosis in the testis. Endocrinol 1997; 138: 2081-2088.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abend, M., Schmelz, HU., Kraft, K. et al. Modified approach for apoptosis detection reveals changes in apoptotic processes in the seminoma-associated tissue. Apoptosis 4, 283–290 (1999). https://doi.org/10.1023/A:1026409027663

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026409027663

Navigation